{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:24:32Z","timestamp":1770229472615,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203850"],"award-info":[{"award-number":["82203850"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Funding Program for Excellent Postdoctoral Talent","award":["2022ZB427"],"award-info":[{"award-number":["2022ZB427"]}]},{"name":"Postdoctoral International Exchange Program","award":["YJ20220433"],"award-info":[{"award-number":["YJ20220433"]}]},{"name":"Chinese Medicine Project of Health Commission of Hubei Province","award":["ZY2021Z010"],"award-info":[{"award-number":["ZY2021Z010"]}]},{"name":"Advantages Discipline Group (Medicine) Project in Higher Education of Hubei Province","award":["2022XKQY3"],"award-info":[{"award-number":["2022XKQY3"]}]},{"name":"Science and Technology Development Fund, Macau SAR","award":["0098\/2021\/A2"],"award-info":[{"award-number":["0098\/2021\/A2"]}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Big Data"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Nonalcoholic fatty liver disease (NAFLD) is a leading public health problem worldwide. Approximately one fourth of patients with nonalcoholic fatty liver (NAFL) progress to nonalcoholic steatohepatitis (NASH), an advanced stage of NAFLD. Hence, there is an urgent need to make a better understanding of NAFLD heterogeneity and facilitate personalized management of high-risk NAFLD patients who may benefit from more intensive surveillance and preventive intervene.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, a series of bioinformatic methods were performed to identify NAFLD progression-specific pathways and genes, and three machine learning approaches were combined to construct a risk-stratification gene signature to quantify risk assessment. In addition, bulk RNA-seq, single-cell RNA-seq (scRNA-seq) transcriptome profiling data and whole-exome sequencing (WES) data were comprehensively analyzed to reveal the genomic alterations and altered pathways between distinct molecular subtypes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Two distinct subtypes of NAFL were identified with the NAFLD progression-specific genes, and one subtype has a high similarity of the inflammatory pattern and fibrotic potential with NASH. The established risk-stratification gene signature could discriminate advanced samples from overall NAFLD. COL1A2, one key gene closely related to NAFLD progression, is specifically expressed in fibroblasts involved in hepatocellular carcinoma (HCC), and significantly correlated with EMT and angiogenesis in pan-cancer. Moreover, the \u03b2-catenin\/COL1A2 axis might play a critical role in fibrosis severity and inflammatory response during NAFLD-HCC progression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In summary, our study provided evidence for the necessity of molecular classification and established a risk-stratification gene signature to quantify risk assessment of NAFLD, aiming to identify different risk subsets and to guide personalized treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40537-024-00899-5","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T03:01:37Z","timestamp":1710471697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Integration of transcriptomic analysis and multiple machine learning approaches identifies NAFLD progression-specific hub genes to reveal distinct genomic patterns and actionable targets"],"prefix":"10.1186","volume":"11","author":[{"given":"Jing","family":"Sun","sequence":"first","affiliation":[]},{"given":"Run","family":"Shi","sequence":"additional","affiliation":[]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Yan","family":"Lou","sequence":"additional","affiliation":[]},{"given":"Lijuan","family":"Nie","sequence":"additional","affiliation":[]},{"given":"Chun","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Yutian","family":"Cao","sequence":"additional","affiliation":[]},{"given":"Qianhua","family":"Yan","sequence":"additional","affiliation":[]},{"given":"Lifang","family":"Ye","sequence":"additional","affiliation":[]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Xuanbin","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Qibiao","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Xuehua","family":"Jiao","sequence":"additional","affiliation":[]},{"given":"Jiangyi","family":"Yu","sequence":"additional","affiliation":[]},{"given":"Zhuyuan","family":"Fang","sequence":"additional","affiliation":[]},{"given":"Xiqiao","family":"Zhou","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"issue":"7","key":"899_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","volume":"6","author":"G Targher","year":"2021","unstructured":"Targher G, Tilg H, Byrne CD. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol Hepatol. 2021;6(7):578\u201388.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"899_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol. 2019;70(3):531\u201344.","journal-title":"J Hepatol"},{"issue":"21","key":"899_CR3","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","volume":"377","author":"AM Diehl","year":"2017","unstructured":"Diehl AM, Day C. Cause, Pathogenesis, and treatment of Nonalcoholic Steatohepatitis. N Engl J Med. 2017;377(21):2063\u201372.","journal-title":"N Engl J Med"},{"issue":"4","key":"899_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223\u201338.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"899_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","volume":"7","author":"N Stefan","year":"2019","unstructured":"Stefan N, Haring HU, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 2019;7(4):313\u201324.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"899_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038\u201348.","journal-title":"Metabolism"},{"issue":"18","key":"899_CR7","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75(18):3313\u201327.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"899_CR8","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.31518","volume":"73","author":"H Tilg","year":"2021","unstructured":"Tilg H, Adolph TE, Moschen AR. Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: Revisited after a Decade. Hepatology. 2021;73(2):833\u201342.","journal-title":"Hepatology"},{"issue":"6","key":"899_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","volume":"44","author":"JW Haukeland","year":"2006","unstructured":"Haukeland JW, Damas JK, Konopski Z, Loberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjoro K, Aukrust P. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol. 2006;44(6):1167\u201374.","journal-title":"J Hepatol"},{"issue":"11","key":"899_CR10","doi-asserted-by":"publisher","first-page":"G1310","DOI":"10.1152\/ajpgi.00365.2011","volume":"302","author":"K Miura","year":"2012","unstructured":"Miura K, Yang L, van Rooijen N, Ohnishi H, Seki E. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am J Physiol Gastrointest Liver Physiol. 2012;302(11):G1310\u20131321.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"899_CR11","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1002\/hep.31995","volume":"74","author":"K Kozumi","year":"2021","unstructured":"Kozumi K, Kodama T, Murai H, Sakane S, Govaere O, Cockell S, Motooka D, Kakita N, Yamada Y, Kondo Y, et al. Transcriptomics identify Thrombospondin-2 as a biomarker for NASH and Advanced Liver Fibrosis. Hepatology. 2021;74(5):2452\u201366.","journal-title":"Hepatology"},{"issue":"1","key":"899_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep4.1789","volume":"6","author":"S Subudhi","year":"2022","unstructured":"Subudhi S, Drescher HK, Dichtel LE, Bartsch LM, Chung RT, Hutter MM, Gee DW, Meireles OR, Witkowski ER, Gelrud L, et al. Distinct hepatic gene-expression patterns of NAFLD in patients with obesity. Hepatol Commun. 2022;6(1):77\u201389.","journal-title":"Hepatol Commun"},{"key":"899_CR13","doi-asserted-by":"crossref","unstructured":"Govaere O, Cockell S, Tiniakos D, Queen R, Younes R, Vacca M, Alexander L, Ravaioli F, Palmer J, Petta S et al. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Sci Transl Med 2020, 12(572).","DOI":"10.1126\/scitranslmed.aba4448"},{"issue":"4","key":"899_CR14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jhep.2021.04.049","volume":"75","author":"R Pinyol","year":"2021","unstructured":"Pinyol R, Torrecilla S, Wang H, Montironi C, Pique-Gili M, Torres-Martin M, Wei-Qiang L, Willoughby CE, Ramadori P, Andreu-Oller C, et al. Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol. 2021;75(4):865\u201378.","journal-title":"J Hepatol"},{"issue":"7","key":"899_CR15","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"Cancer Genome Atlas Research Network","year":"2017","unstructured":"Cancer Genome Atlas Research Network. Electronic address wbe, Cancer Genome Atlas Research N: Comprehensive and Integrative genomic characterization of Hepatocellular Carcinoma. Cell. 2017;169(7):1327\u201341. e1323.","journal-title":"Cell"},{"issue":"6","key":"899_CR16","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"GT Consortium","year":"2013","unstructured":"Consortium GT. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45(6):580\u20135.","journal-title":"Nat Genet"},{"issue":"4","key":"899_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccell.2019.08.007","volume":"36","author":"L Ma","year":"2019","unstructured":"Ma L, Hernandez MO, Zhao Y, Mehta M, Tran B, Kelly M, Rae Z, Hernandez JM, Davis JL, Martin SP, et al. Tumor Cell Biodiversity drives Microenvironmental Reprogramming in Liver Cancer. Cancer Cell. 2019;36(4):418\u2013e430416.","journal-title":"Cancer Cell"},{"issue":"12","key":"899_CR18","doi-asserted-by":"publisher","first-page":"e9682","DOI":"10.15252\/msb.20209682","volume":"16","author":"H Massalha","year":"2020","unstructured":"Massalha H, Bahar Halpern K, Abu-Gazala S, Jana T, Massasa EE, Moor AE, Buchauer L, Rozenberg M, Pikarsky E, Amit I, et al. A single cell atlas of the human liver tumor microenvironment. Mol Syst Biol. 2020;16(12):e9682.","journal-title":"Mol Syst Biol"},{"issue":"11","key":"899_CR19","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1158\/0008-5472.CAN-20-3175","volume":"81","author":"Y Meng","year":"2021","unstructured":"Meng Y, Zhao Q, An L, Jiao S, Li R, Sang Y, Liao J, Nie P, Wen F, Ju J, et al. A TNFR2-hnRNPK Axis promotes primary Liver Cancer Development via activation of YAP Signaling in hepatic progenitor cells. Cancer Res. 2021;81(11):3036\u201350.","journal-title":"Cancer Res"},{"key":"899_CR20","doi-asserted-by":"publisher","first-page":"175883592093790","DOI":"10.1177\/1758835920937904","volume":"12","author":"J Sun","year":"2020","unstructured":"Sun J, Zhao T, Zhao D, Qi X, Bao X, Shi R, Su C. Development and validation of a hypoxia-related gene signature to predict overall survival in early-stage lung adenocarcinoma patients. Ther Adv Med Oncol. 2020;12:1758835920937904.","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"899_CR21","doi-asserted-by":"publisher","first-page":"e1964189","DOI":"10.1080\/2162402X.2021.1964189","volume":"10","author":"J Sun","year":"2021","unstructured":"Sun J, Shi R, Zhang X, Fang D, Rauch J, Lu S, Wang X, Kasmann L, Ma J, Belka C, et al. Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy. Oncoimmunology. 2021;10(1):e1964189.","journal-title":"Oncoimmunology"},{"issue":"10","key":"899_CR22","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.7150\/thno.56202","volume":"11","author":"R Shi","year":"2021","unstructured":"Shi R, Bao X, Unger K, Sun J, Lu S, Manapov F, Wang X, Belka C, Li M. Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients. Theranostics. 2021;11(10):5061\u201376.","journal-title":"Theranostics"},{"key":"899_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"5795","key":"899_CR24","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929\u201335.","journal-title":"Science"},{"issue":"21","key":"899_CR25","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: a web server for Comprehensive Analysis of Tumor-infiltrating Immune cells. Cancer Res. 2017;77(21):e108\u201310.","journal-title":"Cancer Res"},{"issue":"7","key":"899_CR26","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA, Steiner D, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773\u201382.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"899_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello F, Mayer C, Plattner C, Laschober G, Rieder D, Hackl H, Krogsdam A, Loncova Z, Posch W, Wilflingseder D, et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 2019;11(1):34.","journal-title":"Genome Med"},{"issue":"1","key":"899_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Sautes-Fridman C, Fridman WH, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218.","journal-title":"Genome Biol"},{"issue":"1","key":"899_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220.","journal-title":"Genome Biol"},{"key":"899_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-1-0716-0327-7_17","volume":"2120","author":"J Racle","year":"2020","unstructured":"Racle J, Gfeller D. EPIC: a Tool to Estimate the proportions of different cell types from bulk gene expression data. Methods Mol Biol. 2020;2120:233\u201348.","journal-title":"Methods Mol Biol"},{"key":"899_CR31","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, Trevino V, Shen H, Laird PW, Levine DA, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"11","key":"899_CR32","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356.","journal-title":"Genome Res"},{"issue":"5","key":"899_CR33","doi-asserted-by":"publisher","first-page":"e1009557","DOI":"10.1371\/journal.pgen.1009557","volume":"17","author":"S Wang","year":"2021","unstructured":"Wang S, Li H, Song M, Tao Z, Wu T, He Z, Zhao X, Wu K, Liu XS. Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes. PLoS Genet. 2021;17(5):e1009557.","journal-title":"PLoS Genet"},{"issue":"9","key":"899_CR34","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.7150\/thno.73235","volume":"12","author":"R Shi","year":"2022","unstructured":"Shi R, Wang X, Wu Y, Xu B, Zhao T, Trapp C, Wang X, Unger K, Zhou C, Lu S, et al. APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases. Theranostics. 2022;12(9):4181\u201399.","journal-title":"Theranostics"},{"issue":"7","key":"899_CR35","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1158\/1078-0432.CCR-18-2293","volume":"25","author":"JJ Harding","year":"2019","unstructured":"Harding JJ, Nandakumar S, Armenia J, Khalil DN, Albano M, Ly M, Shia J, Hechtman JF, Kundra R, El Dika I, et al. Prospective genotyping of Hepatocellular Carcinoma: clinical implications of Next-Generation sequencing for matching patients to targeted and Immune therapies. Clin Cancer Res. 2019;25(7):2116\u201326.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"899_CR36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ng.3252","volume":"47","author":"K Schulze","year":"2015","unstructured":"Schulze K, Imbeaud S, Letouze E, Alexandrov LB, Calderaro J, Rebouissou S, Couchy G, Meiller C, Shinde J, Soysouvanh F, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet. 2015;47(5):505\u201311.","journal-title":"Nat Genet"},{"issue":"7","key":"899_CR37","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1093\/bioinformatics\/btq064","volume":"26","author":"G Yu","year":"2010","unstructured":"Yu G, Li F, Qin Y, Bo X, Wu Y, Wang S. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products. Bioinformatics. 2010;26(7):976\u20138.","journal-title":"Bioinformatics"},{"issue":"12","key":"899_CR38","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1093\/molbev\/msy194","volume":"35","author":"G Yu","year":"2018","unstructured":"Yu G, Lam TT, Zhu H, Guan Y. Two methods for mapping and visualizing Associated Data on Phylogeny using Ggtree. Mol Biol Evol. 2018;35(12):3041\u20133.","journal-title":"Mol Biol Evol"},{"issue":"6","key":"899_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"4","key":"899_CR40","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41401-021-00725-1","volume":"43","author":"HM Huang","year":"2022","unstructured":"Huang HM, Fan SJ, Zhou XR, Liu YJ, Li X, Liao LP, Huang J, Shi CC, Yu L, Fu R, et al. Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis. Acta Pharmacol Sin. 2022;43(4):941\u201353.","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"899_CR41","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nri1412","volume":"4","author":"TA Wynn","year":"2004","unstructured":"Wynn TA. Fibrotic disease and the T(H)1\/T(H)2 paradigm. Nat Rev Immunol. 2004;4(8):583\u201394.","journal-title":"Nat Rev Immunol"},{"key":"899_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2014.00123","volume":"5","author":"RT Kendall","year":"2014","unstructured":"Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol. 2014;5:123.","journal-title":"Front Pharmacol"},{"issue":"6","key":"899_CR43","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.matbio.2006.05.002","volume":"25","author":"F Ramirez","year":"2006","unstructured":"Ramirez F, Tanaka S, Bou-Gharios G. Transcriptional regulation of the human alpha2(I) collagen gene (COL1A2), an informative model system to study fibrotic diseases. Matrix Biol. 2006;25(6):365\u201372.","journal-title":"Matrix Biol"},{"key":"899_CR44","doi-asserted-by":"publisher","first-page":"967016","DOI":"10.3389\/fendo.2022.967016","volume":"13","author":"R Gao","year":"2022","unstructured":"Gao R, Wang J, He X, Wang T, Zhou L, Ren Z, Yang J, Xiang X, Wen S, Yu Z, et al. Comprehensive analysis of endoplasmic reticulum-related and secretome gene expression profiles in the progression of non-alcoholic fatty liver disease. Front Endocrinol (Lausanne). 2022;13:967016.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"899_CR45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s41065-021-00196-8","volume":"158","author":"J Zheng","year":"2021","unstructured":"Zheng J, Wu H, Zhang Z, Yao S. Dynamic co-expression modular network analysis in nonalcoholic fatty liver disease. Hereditas. 2021;158(1):31.","journal-title":"Hereditas"}],"container-title":["Journal of Big Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40537-024-00899-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40537-024-00899-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40537-024-00899-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T04:54:21Z","timestamp":1710478461000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalofbigdata.springeropen.com\/articles\/10.1186\/s40537-024-00899-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["899"],"URL":"https:\/\/doi.org\/10.1186\/s40537-024-00899-5","relation":{},"ISSN":["2196-1115"],"issn-type":[{"value":"2196-1115","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]},"assertion":[{"value":"25 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is based on published or public datasets and does not require ethical approval and consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"40"}}